BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27119637)

  • 1. The Pathogenic A116V Mutation Enhances Ion-Selective Channel Formation by Prion Protein in Membranes.
    Sabareesan AT; Singh J; Roy S; Udgaonkar JB; Mathew MK
    Biophys J; 2016 Apr; 110(8):1766-1776. PubMed ID: 27119637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Transgenic Mouse Model of Gerstmann-Straussler-Scheinker Syndrome Caused by the A117V Mutation of PRNP.
    Yang W; Cook J; Rassbach B; Lemus A; DeArmond SJ; Mastrianni JA
    J Neurosci; 2009 Aug; 29(32):10072-80. PubMed ID: 19675240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Channels formed with a mutant prion protein PrP(82-146) homologous to a 7-kDa fragment in diseased brain of GSS patients.
    Bahadi R; Farrelly PV; Kenna BL; Kourie JI; Tagliavini F; Forloni G; Salmona M
    Am J Physiol Cell Physiol; 2003 Oct; 285(4):C862-72. PubMed ID: 12814912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.
    Elezgarai SR; Fernández-Borges N; Eraña H; Sevillano AM; Charco JM; Harrathi C; Saá P; Gil D; Kong Q; Requena JR; Andréoletti O; Castilla J
    Sci Rep; 2017 Aug; 7(1):9584. PubMed ID: 28851967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic Mutations within the Disordered Palindromic Region of the Prion Protein Induce Structure Therein and Accelerate the Formation of Misfolded Oligomers.
    Sabareesan AT; Udgaonkar JB
    J Mol Biol; 2016 Oct; 428(20):3935-3947. PubMed ID: 27545411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of lipid on conformational conversion of chicken and murine prion proteins.
    Wang LJ; Gu XD; Yu GH; Shen L; Ji HF
    Vet Microbiol; 2018 Oct; 224():1-7. PubMed ID: 30269782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Models of Inherited PrP Prion Diseases.
    Watts JC; Prusiner SB
    Cold Spring Harb Perspect Med; 2017 Nov; 7(11):. PubMed ID: 28096244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Domain Structure of the Prion Protein Caused by Cu
    McDonald AJ; Leon DR; Markham KA; Wu B; Heckendorf CF; Schilling K; Showalter HD; Andrews PC; McComb ME; Pushie MJ; Costello CE; Millhauser GL; Harris DA
    Structure; 2019 Jun; 27(6):907-922.e5. PubMed ID: 30956132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains.
    Tremblay P; Ball HL; Kaneko K; Groth D; Hegde RS; Cohen FE; DeArmond SJ; Prusiner SB; Safar JG
    J Virol; 2004 Feb; 78(4):2088-99. PubMed ID: 14747574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Structural Characterization of the Precursor Conformation of the Prion Protein which Directly Initiates Misfolding and Oligomerization.
    Moulick R; Udgaonkar JB
    J Mol Biol; 2017 Mar; 429(6):886-899. PubMed ID: 28147229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nascent β Structure in the Elongated Hydrophobic Region of a Gerstmann-Sträussler-Scheinker PrP Allele.
    Fu ZL; Holmes PC; Westaway D; Sykes BD
    J Mol Biol; 2019 Jun; 431(14):2599-2611. PubMed ID: 31034890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gerstmann-Sträussler-Scheinker disease subtypes efficiently transmit in bank voles as genuine prion diseases.
    Pirisinu L; Di Bari MA; D'Agostino C; Marcon S; Riccardi G; Poleggi A; Cohen ML; Appleby BS; Gambetti P; Ghetti B; Agrimi U; Nonno R
    Sci Rep; 2016 Feb; 6():20443. PubMed ID: 26841849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IVIG Delays Onset in a Mouse Model of Gerstmann-Sträussler-Scheinker Disease.
    Gu H; Kirchhein Y; Zhu T; Zhao G; Peng H; Du E; Liu J; Mastrianni JA; Farlow MR; Dodel R; Du Y
    Mol Neurobiol; 2019 Apr; 56(4):2353-2361. PubMed ID: 30027340
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anle138b prevents PrP plaque accumulation in Tg(PrP-A116V) mice but does not mitigate clinical disease.
    Qin K; Zhao L; Solanki A; Busch C; Mastrianni J
    J Gen Virol; 2019 Jun; 100(6):1027-1037. PubMed ID: 31045489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Channel Activities of the Full-Length Prion and Truncated Proteins.
    Wu J; Wang X; Lakkaraju A; Sternke-Hoffmann R; Qureshi BM; Aguzzi A; Luo J
    ACS Chem Neurosci; 2024 Jan; 15(1):98-107. PubMed ID: 38096481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.